Loading…
Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population
Aims To examine the value of N-terminal pro-brain natriuretic peptide, abnormal electrocardiogram and other baseline clinical and laboratory variables in identifying patients with left ventricular systolic dysfunction in a high risk population. Methods and Results We studied 243 patients (129 male,...
Saved in:
| Published in: | European heart journal 1999-12, Vol.20 (23), p.1736-1744 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c464t-e219ce01899a53c6b476c49030efa7fea73f08ffe55dee6d5a083af3d690d0e93 |
|---|---|
| cites | |
| container_end_page | 1744 |
| container_issue | 23 |
| container_start_page | 1736 |
| container_title | European heart journal |
| container_volume | 20 |
| creator | Talwar, S Squire, I.B Davies, J.E Barnett, D.B Ng, L.L |
| description | Aims To examine the value of N-terminal pro-brain natriuretic peptide, abnormal electrocardiogram and other baseline clinical and laboratory variables in identifying patients with left ventricular systolic dysfunction in a high risk population. Methods and Results We studied 243 patients (129 male, median age 73 years, range 20–94) referred for echocardiography. The relationship between left ventricular wall motion index and log N-terminal pro-brain natriuretic peptide, log creatinine, electrocardiogram, age, history of hypertension, history of ischaemic heart disease, gender, valvular disease and current drug therapy was examined using regression analysis. There was a strong correlation between N-terminal pro-brain natriuretic peptide and left ventricular wall motion index for the whole population (r=−0·624, P |
| doi_str_mv | 10.1053/euhj.1999.1694 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69279731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69279731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-e219ce01899a53c6b476c49030efa7fea73f08ffe55dee6d5a083af3d690d0e93</originalsourceid><addsrcrecordid>eNpNkU2P0zAQhiMEYsvClSPyAXFLsePEiY-oLN2VVsABRMXFmjpj6t184XEQ_Rf85HXUCjjZ1jzvK42fLHsp-FrwSr7F-XC3FlrrtVC6fJStRFUUuVZl9ThbcaGrXKlmd5E9I7rjnDdKqKfZRYqqomyKVfbncwfUA_uYRwy9H6BjUxjzfQA_sAFi8HPA6C2bcIq-RQZDy-IB2dVmyxKyXIEIiXocIhsd69DF_Fd6BG_nDgKjI8WxSxXtkdw82OjHYYkCO_gfBxY83bNpnBK7TJ5nTxx0hC_O52X29cPVl811fvtpe7N5d5vbUpUxx0Joi1w0WkMlrdqXtbKl5pKjg9oh1NLxxjmsqhZRtRXwRoKTrdK85ajlZfbm1JvW_TkjRdN7sth1MOA4k1G6qHUtRQLXJ9CGkSigM1PwPYSjEdwsDsziwCwOzOIgBV6dm-d9j-1_-OnTE_D6DABZ6FyAwXr6xxXJm2oSlp8wTxF__x1DuDeqlnVlrnffjdpud418_80U8gG9zqIt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69279731</pqid></control><display><type>article</type><title>Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population</title><source>Oxford Journals Online</source><creator>Talwar, S ; Squire, I.B ; Davies, J.E ; Barnett, D.B ; Ng, L.L</creator><creatorcontrib>Talwar, S ; Squire, I.B ; Davies, J.E ; Barnett, D.B ; Ng, L.L</creatorcontrib><description>Aims To examine the value of N-terminal pro-brain natriuretic peptide, abnormal electrocardiogram and other baseline clinical and laboratory variables in identifying patients with left ventricular systolic dysfunction in a high risk population. Methods and Results We studied 243 patients (129 male, median age 73 years, range 20–94) referred for echocardiography. The relationship between left ventricular wall motion index and log N-terminal pro-brain natriuretic peptide, log creatinine, electrocardiogram, age, history of hypertension, history of ischaemic heart disease, gender, valvular disease and current drug therapy was examined using regression analysis. There was a strong correlation between N-terminal pro-brain natriuretic peptide and left ventricular wall motion index for the whole population (r=−0·624, P<0·001) and in those receiving diuretic±angiotensin converting enzyme inhibitor (r= −0·661, P<0·005) and in those receiving neither (r=−0·584,P <0·005). On multiple regression analysis, log N-terminal pro-brain natriuretic peptide (P<0·001), age (P=0·015), current diuretic (P=0·002) or angiotensin converting enzyme inhibitor use (P=0·001) and male gender (P=0·026) were independently associated with a low left ventricular wall motion index. Log N-terminal pro-brain natriuretic peptide alone (R2=39%) was a better predictor of left ventricular wall motion index than any other single or combination of factors. Plasma N-terminal pro-brain natriuretic peptide>275pmoll−1predicted left ventricular wall motion index ≤1·2 with a sensitivity of 93·8%, a specificity of 55% and a negative predictive value of 93%. Left ventricular function was impaired in 18/36 patients with a normal electrocardiogram, in all of whom N-terminal pro-brain natriuretic peptide was >275fmolml−1. Conclusion Of the variables studies, N-terminal pro-brain natriuretic peptide had the strongest correlation with reduced left ventricular wall motion index. The electrocardiogram had a poor predictive value for left ventricular systolic dysfunction in this population. Plasma N-terminal pro-brain natriuretic peptide can usefully predict patients with a reduced left ventricular wall motion index in whom echocardiographic examination may be appropriate.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1053/euhj.1999.1694</identifier><identifier>PMID: 10562482</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biomarkers - blood ; brain natriuretic peptide ; Cardiology. Vascular system ; chemiluminescence ; Echocardiography, Doppler, Color ; Electrocardiography ; Female ; Heart ; Heart failure ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Humans ; Male ; Medical sciences ; Middle Aged ; Natriuretic Peptide, Brain ; Nerve Tissue Proteins - blood ; Peptide Fragments - blood ; plasma ; Prognosis ; Severity of Illness Index ; Systole - physiology ; Ventricular Dysfunction, Left - blood ; Ventricular Dysfunction, Left - diagnostic imaging ; Ventricular Dysfunction, Left - physiopathology ; wall motion index</subject><ispartof>European heart journal, 1999-12, Vol.20 (23), p.1736-1744</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright 1999 The European Society of Cardiology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-e219ce01899a53c6b476c49030efa7fea73f08ffe55dee6d5a083af3d690d0e93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1201968$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10562482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Talwar, S</creatorcontrib><creatorcontrib>Squire, I.B</creatorcontrib><creatorcontrib>Davies, J.E</creatorcontrib><creatorcontrib>Barnett, D.B</creatorcontrib><creatorcontrib>Ng, L.L</creatorcontrib><title>Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Aims To examine the value of N-terminal pro-brain natriuretic peptide, abnormal electrocardiogram and other baseline clinical and laboratory variables in identifying patients with left ventricular systolic dysfunction in a high risk population. Methods and Results We studied 243 patients (129 male, median age 73 years, range 20–94) referred for echocardiography. The relationship between left ventricular wall motion index and log N-terminal pro-brain natriuretic peptide, log creatinine, electrocardiogram, age, history of hypertension, history of ischaemic heart disease, gender, valvular disease and current drug therapy was examined using regression analysis. There was a strong correlation between N-terminal pro-brain natriuretic peptide and left ventricular wall motion index for the whole population (r=−0·624, P<0·001) and in those receiving diuretic±angiotensin converting enzyme inhibitor (r= −0·661, P<0·005) and in those receiving neither (r=−0·584,P <0·005). On multiple regression analysis, log N-terminal pro-brain natriuretic peptide (P<0·001), age (P=0·015), current diuretic (P=0·002) or angiotensin converting enzyme inhibitor use (P=0·001) and male gender (P=0·026) were independently associated with a low left ventricular wall motion index. Log N-terminal pro-brain natriuretic peptide alone (R2=39%) was a better predictor of left ventricular wall motion index than any other single or combination of factors. Plasma N-terminal pro-brain natriuretic peptide>275pmoll−1predicted left ventricular wall motion index ≤1·2 with a sensitivity of 93·8%, a specificity of 55% and a negative predictive value of 93%. Left ventricular function was impaired in 18/36 patients with a normal electrocardiogram, in all of whom N-terminal pro-brain natriuretic peptide was >275fmolml−1. Conclusion Of the variables studies, N-terminal pro-brain natriuretic peptide had the strongest correlation with reduced left ventricular wall motion index. The electrocardiogram had a poor predictive value for left ventricular systolic dysfunction in this population. Plasma N-terminal pro-brain natriuretic peptide can usefully predict patients with a reduced left ventricular wall motion index in whom echocardiographic examination may be appropriate.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>brain natriuretic peptide</subject><subject>Cardiology. Vascular system</subject><subject>chemiluminescence</subject><subject>Echocardiography, Doppler, Color</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Heart</subject><subject>Heart failure</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain</subject><subject>Nerve Tissue Proteins - blood</subject><subject>Peptide Fragments - blood</subject><subject>plasma</subject><subject>Prognosis</subject><subject>Severity of Illness Index</subject><subject>Systole - physiology</subject><subject>Ventricular Dysfunction, Left - blood</subject><subject>Ventricular Dysfunction, Left - diagnostic imaging</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><subject>wall motion index</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpNkU2P0zAQhiMEYsvClSPyAXFLsePEiY-oLN2VVsABRMXFmjpj6t184XEQ_Rf85HXUCjjZ1jzvK42fLHsp-FrwSr7F-XC3FlrrtVC6fJStRFUUuVZl9ThbcaGrXKlmd5E9I7rjnDdKqKfZRYqqomyKVfbncwfUA_uYRwy9H6BjUxjzfQA_sAFi8HPA6C2bcIq-RQZDy-IB2dVmyxKyXIEIiXocIhsd69DF_Fd6BG_nDgKjI8WxSxXtkdw82OjHYYkCO_gfBxY83bNpnBK7TJ5nTxx0hC_O52X29cPVl811fvtpe7N5d5vbUpUxx0Joi1w0WkMlrdqXtbKl5pKjg9oh1NLxxjmsqhZRtRXwRoKTrdK85ajlZfbm1JvW_TkjRdN7sth1MOA4k1G6qHUtRQLXJ9CGkSigM1PwPYSjEdwsDsziwCwOzOIgBV6dm-d9j-1_-OnTE_D6DABZ6FyAwXr6xxXJm2oSlp8wTxF__x1DuDeqlnVlrnffjdpud418_80U8gG9zqIt</recordid><startdate>19991201</startdate><enddate>19991201</enddate><creator>Talwar, S</creator><creator>Squire, I.B</creator><creator>Davies, J.E</creator><creator>Barnett, D.B</creator><creator>Ng, L.L</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991201</creationdate><title>Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population</title><author>Talwar, S ; Squire, I.B ; Davies, J.E ; Barnett, D.B ; Ng, L.L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-e219ce01899a53c6b476c49030efa7fea73f08ffe55dee6d5a083af3d690d0e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>brain natriuretic peptide</topic><topic>Cardiology. Vascular system</topic><topic>chemiluminescence</topic><topic>Echocardiography, Doppler, Color</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Heart</topic><topic>Heart failure</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain</topic><topic>Nerve Tissue Proteins - blood</topic><topic>Peptide Fragments - blood</topic><topic>plasma</topic><topic>Prognosis</topic><topic>Severity of Illness Index</topic><topic>Systole - physiology</topic><topic>Ventricular Dysfunction, Left - blood</topic><topic>Ventricular Dysfunction, Left - diagnostic imaging</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><topic>wall motion index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Talwar, S</creatorcontrib><creatorcontrib>Squire, I.B</creatorcontrib><creatorcontrib>Davies, J.E</creatorcontrib><creatorcontrib>Barnett, D.B</creatorcontrib><creatorcontrib>Ng, L.L</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Talwar, S</au><au>Squire, I.B</au><au>Davies, J.E</au><au>Barnett, D.B</au><au>Ng, L.L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>1999-12-01</date><risdate>1999</risdate><volume>20</volume><issue>23</issue><spage>1736</spage><epage>1744</epage><pages>1736-1744</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Aims To examine the value of N-terminal pro-brain natriuretic peptide, abnormal electrocardiogram and other baseline clinical and laboratory variables in identifying patients with left ventricular systolic dysfunction in a high risk population. Methods and Results We studied 243 patients (129 male, median age 73 years, range 20–94) referred for echocardiography. The relationship between left ventricular wall motion index and log N-terminal pro-brain natriuretic peptide, log creatinine, electrocardiogram, age, history of hypertension, history of ischaemic heart disease, gender, valvular disease and current drug therapy was examined using regression analysis. There was a strong correlation between N-terminal pro-brain natriuretic peptide and left ventricular wall motion index for the whole population (r=−0·624, P<0·001) and in those receiving diuretic±angiotensin converting enzyme inhibitor (r= −0·661, P<0·005) and in those receiving neither (r=−0·584,P <0·005). On multiple regression analysis, log N-terminal pro-brain natriuretic peptide (P<0·001), age (P=0·015), current diuretic (P=0·002) or angiotensin converting enzyme inhibitor use (P=0·001) and male gender (P=0·026) were independently associated with a low left ventricular wall motion index. Log N-terminal pro-brain natriuretic peptide alone (R2=39%) was a better predictor of left ventricular wall motion index than any other single or combination of factors. Plasma N-terminal pro-brain natriuretic peptide>275pmoll−1predicted left ventricular wall motion index ≤1·2 with a sensitivity of 93·8%, a specificity of 55% and a negative predictive value of 93%. Left ventricular function was impaired in 18/36 patients with a normal electrocardiogram, in all of whom N-terminal pro-brain natriuretic peptide was >275fmolml−1. Conclusion Of the variables studies, N-terminal pro-brain natriuretic peptide had the strongest correlation with reduced left ventricular wall motion index. The electrocardiogram had a poor predictive value for left ventricular systolic dysfunction in this population. Plasma N-terminal pro-brain natriuretic peptide can usefully predict patients with a reduced left ventricular wall motion index in whom echocardiographic examination may be appropriate.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>10562482</pmid><doi>10.1053/euhj.1999.1694</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-668X |
| ispartof | European heart journal, 1999-12, Vol.20 (23), p.1736-1744 |
| issn | 0195-668X 1522-9645 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69279731 |
| source | Oxford Journals Online |
| subjects | Adult Aged Aged, 80 and over Biological and medical sciences Biomarkers - blood brain natriuretic peptide Cardiology. Vascular system chemiluminescence Echocardiography, Doppler, Color Electrocardiography Female Heart Heart failure Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Male Medical sciences Middle Aged Natriuretic Peptide, Brain Nerve Tissue Proteins - blood Peptide Fragments - blood plasma Prognosis Severity of Illness Index Systole - physiology Ventricular Dysfunction, Left - blood Ventricular Dysfunction, Left - diagnostic imaging Ventricular Dysfunction, Left - physiopathology wall motion index |
| title | Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A14%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20N-terminal%20pro-brain%20natriuretic%20peptide%20and%20the%20ECG%20in%20the%20assessment%20of%20left-ventricular%20systolic%20dysfunction%20in%20a%20high%20risk%20population&rft.jtitle=European%20heart%20journal&rft.au=Talwar,%20S&rft.date=1999-12-01&rft.volume=20&rft.issue=23&rft.spage=1736&rft.epage=1744&rft.pages=1736-1744&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1053/euhj.1999.1694&rft_dat=%3Cproquest_cross%3E69279731%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-e219ce01899a53c6b476c49030efa7fea73f08ffe55dee6d5a083af3d690d0e93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69279731&rft_id=info:pmid/10562482&rfr_iscdi=true |